Adheris Health Limited has released a press release.
Major Biopharmaceutical Signs to Patient Engagement Program
Filed with ASX ·
Watch Adheris Health's latest callMedAdvisor Limited (MDR) Q1 2026 Earnings Call · Replay · Oct 21, 2025Read the transcript of MedAdvisor Limited (MDR) Q1 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Adheris Health
- Strong Growth in Key Business Drivers
- GlaxoSmithKline Extends Service Agreement with MedAdvisor
- Sales Channel Secured with Arrow Pharmaceuticals
- Novartis Pharmaceuticals Australia to use MedAdvisor
- MDR Quarterly Activities Report and Appendix 4C
Later from Adheris Health
- Quarterly Activities Report and Appendix 4C - June 16
- Glaucoma Australia Partnership to assist 300,000 Australians
- MedAdvisor launches new NDSS feature with Diabetes Aust
- Appendix 4E and Preliminary Financial Report
- MedAdvisor to Acquire Healthnotes to Accelerate Growth
Follow Adheris Health into a list and get an email when it puts out news.
Follow Adheris Health